Sandrine Compagnie
Overview
Explore the profile of Sandrine Compagnie including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
90
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Assaly R, Faugeroux J, Laurin M, Compagnie S, Alexandre L, Giuliano F, et al.
BMC Urol
. 2020 Aug;
20(1):132.
PMID: 32854676
Background: The main purpose of this study is to investigate the effect of silodosin on the urodynamic consequences in a previously established model of lower urinary tract symptoms associated with...
2.
Assaly R, Gorny D, Compagnie S, Mayoux E, Bernabe J, Alexandre L, et al.
J Sex Med
. 2018 Aug;
15(9):1224-1234.
PMID: 30145094
Introduction: Following the results of the EMPA-REG Outcome trial, we hypothesized that empagliflozin, a highly potent and specific sodium/glucose cotransporteur 2 inhibitor, could improve type 2 diabetes mellitus (T2DM)-associated erectile...
3.
Huynh Le Maux A, Pignol B, Behr-Roussel D, Blachon J, Chabrier P, Compagnie S, et al.
Toxins (Basel)
. 2015 Dec;
7(12):5462-71.
PMID: 26694464
Intradetrusor injections of Botulinum toxin A-currently onabotulinumtoxinA-is registered as a second-line treatment to treat neurogenic detrusor overactivity (NDO). The common clinical practice is 30 × 1 mL injections in the...
4.
Gelez H, Clement P, Compagnie S, Gorny D, Laurin M, Allers K, et al.
Psychopharmacology (Berl)
. 2013 Jul;
230(4):639-52.
PMID: 23857113
Rationale: Flibanserin, a 5-HT1A agonist and 5-HT2A antagonist, is developed for the treatment of hypoactive sexual desire disorder in women, and its efficacy has been evidenced in several clinical studies....
5.
Clement P, Bernabe J, Compagnie S, Alexandre L, McCallum S, Giuliano F
Br J Pharmacol
. 2013 Mar;
169(7):1477-85.
PMID: 23530818
Background And Purpose: Oxytocin (OT) plays a major role in the control of male sexual responses. Notably, blockade of OT receptors has been reported to inhibit ejaculation in animals. The...
6.
Clement P, Laurin M, Compagnie S, Facchinetti P, Bernabe J, Alexandre L, et al.
J Sex Med
. 2012 Aug;
9(10):2562-73.
PMID: 22906232
Introduction: A brain network specifically activated when ejaculation occurs has been described in rats. Increasing serotonin (5-hydroxytryptamine [5-HT]) tone impairs ejaculation and chronic 5-HT selective serotonin reuptake inhibitors (SSRIs) are...
7.
Behr-Roussel D, Oger S, Pignol B, Pham E, Le Maux A, Chabrier P, et al.
Eur Urol
. 2012 Feb;
61(5):1054-61.
PMID: 22341129
Background: Two botulinum toxins A have been evaluated for the treatment of refractory neurogenic detrusor overactivity (NDO) in humans: Dysport (abobotulinumtoxinA) and Botox (onabotulinumtoxinA). However, these two distinct commercialized products...
8.
Behr-Roussel D, Oudot A, Compagnie S, Gorny D, Le Coz O, Bernabe J, et al.
Am J Hypertens
. 2008 Sep;
21(11):1258-63.
PMID: 18787522
Background: Insulin resistance constitutes a risk factor for endothelial dysfunction and subsequent cardiovascular diseases including hypertension. Daily treatment with phosphodiesterase type 5 (PDE5) inhibitors has beneficial effects on endothelial function...
9.
Behr-Roussel D, Darblade B, Oudot A, Compagnie S, Bernabe J, Alexandre L, et al.
J Sex Med
. 2006 Jul;
3(4):596-603.
PMID: 16839315
Introduction: Erectile dysfunction (ED) and cardiovascular diseases share the same risk factors. Although the use of hypercholesterolemic rabbit models has proven to be useful to illustrate the link between ED...
10.
Behr-Roussel D, Gorny D, Mevel K, Compagnie S, Kern P, Sivan V, et al.
Am J Physiol Regul Integr Comp Physiol
. 2004 Aug;
288(1):R276-83.
PMID: 15297263
Erectile dysfunction (ED) is another manifestation of vascular disease. We evaluated the natural history of ED in the spontaneously hypertensive rat (SHR) and the respective participation of associated pathophysiological modifications,...